Continuing Medical Education Questions: August 2021

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Chronic abdominal pain (CAP) significantly impacts patient quality of life.
• Antispasmodics are frequently prescribed for functional gastrointestinal disorders causing CAP.
• Understanding North American treatment patterns is crucial for optimizing CAP management.

Purpose of the Study:

• To analyze the current landscape of antispasmodic use for chronic abdominal pain in North America.
• To evaluate the available evidence supporting different antispasmodic agents.
• To identify trends and gaps in the treatment of chronic abdominal pain with antispasmodics.

Main Methods:

• Systematic review of literature on antispasmodics for chronic abdominal pain.
• Analysis of treatment guidelines and clinical practice patterns in North America.
• Assessment of efficacy and safety data for commonly used antispasmodics.

Main Results:

• A variety of antispasmodics are utilized, with varying degrees of evidence.
• Dosing and specific agent selection often depend on physician preference and local formulary.
• Limited head-to-head comparisons exist for many agents in the North American context.

Conclusions:

• Antispasmodics remain a cornerstone in managing chronic abdominal pain.
• Further research is needed to establish optimal agent selection and standardized treatment protocols.
• Evidence-based guidelines can improve the consistent and effective use of antispasmodics for chronic abdominal pain.